Dr. Mousami Shah, M.D.
Hematology/oncology
20+
Years in Practice
Practice Locations
10 locations
Advocate Christ Hospital & Medical Center
4440 W 95th Street, Oak Lawn, Illinois, 60453
(708) 684-8000
Advocate Health And Hospitals Corporation
9555 S 52nd Ave, Oak Lawn, Illinois, 60453
(708) 634-0950
Advocate Health And Hospitals Corporation
4440 W 95th St, Oak Lawn, Illinois, 60453
Advocate Health And Hospitals Corporation
4440 W 95th St, Oak Lawn, Illinois, 60453
(708) 684-4393
Advocate Health And Hospitals Corporation
4440 W 95th St, Oak Lawn, Illinois, 60453
(708) 684-8000
Advocate Health And Hospitals Corporation
4440 W 95th St, Oak Lawn, Illinois, 60453
(708) 346-5354
About Dr. Mousami Shah
Mousami Shah, M.D. is a healthcare provider practicing in Oak Lawn, IL.
Specialty Definition
An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
26
Years Experience
10
Locations
1
States Licensed
Credentials & Board Certifications
Primary Specialty
Hematology/oncologyCredentials verified via NPI Registry (NPPES)
Education & Training
Medical School
Other
Class of 2000
Licenses & Practice States
Licensed in 1 state
| State | License | Classification | Primary |
|---|---|---|---|
| Illinois | 036110949 | Internal Medicine |
Public Data Summary for Dr. Mousami Shah
With 20 years of practice, Dr. Mousami Shah is an established hematology/oncology provider, M.D., after earning their medical degree at Other in 2000. Dr. currently practices across 10 facilities, including Advocate Christ Hospital & Medical Center in Oak Lawn, Illinois. Their National Provider Identifier (NPI) is 1043242860, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
CMS Medicare data shows Dr. Mousami Shah as a lower-volume hematology/oncology provider, treating approximately 263 Medicare beneficiaries and delivering 709 services in the most recent reporting year. That panel size indicates a smaller, more selective practice pattern.
Under the Physician Payments Sunshine Act, CMS reports that Dr. Mousami Shah received $149 in industry payments in 2023. Payments at this scale are typical for most practicing physicians and generally reflect routine educational activities.
Transparency & Safety
Public records from CMS and OIG databases
Industry Payments
$149
Total payments received from pharmaceutical and medical device companies in 2023.
Source: CMS Open Payments (Sunshine Act)
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Dr. Mousami Shah
--
0 reviews
Hematology/oncology Providers Nearby
Same primary specialty near ZIP 60453
FAQ
Frequently asked questions about Dr. Mousami Shah
What does Dr. Mousami Shah specialize in?
Dr. Mousami Shah specializes in Hematology/oncology.
Where does Dr. Mousami Shah practice?
Dr. Mousami Shah practices at Advocate Christ Hospital & Medical Center in Oak Lawn, Illinois. Dr. is also affiliated with 9 additional facilities, listed below.
Does Dr. Mousami Shah accept Medicare?
CMS records show that Dr. Mousami Shah accepts Medicare assignment. CMS billing data shows 263 Medicare beneficiaries treated in the most recent reporting year.
What is Dr. Mousami Shah's NPI number?
Dr. Mousami Shah's National Provider Identifier (NPI) is 1043242860. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Dr. Mousami Shah been practicing?
Dr. Mousami Shah has approximately 20 years of practice experience, having graduated from Other in 2000.